+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Biosurgery Market (2019-2025)

  • ID: 4900439
  • Report
  • December 2019
  • Region: Europe
  • 100 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CSL Limited
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi S.A.
The Europe Biosurgery Market is expected to witness market growth of 6% CAGR during the forecast period (2019-2025).

Biosurgery technology has established a new paradigm in wound and tissue management, surgical care, and regenerative healing. Several products under biosurgery have brought in extensive interest among surgeons and patients. This is projected to gain traction in several medical specialties such as gynecology, orthopedic, neurosurgery cardiovascular, and spine-related therapies. The increased need for novel biomaterials for the intra-operative wound as well as tissue management can also be a key trend in improving the biosurgery market. Life sciences companies launch products for surgical care that are highly focused on discovering new avenues in biosurgery by getting involved in relentless development activities.

The European Bio Surgery market's main driver is the strong focus on scientific growth, which in turn leads to the launch of various new products and other technological advances in the area. Along with the growing number of surgeries due to evolving lifestyles and increasing consumer awareness, it will serve as market growth boosters. The main critical factor on the Bio Surgery market in Europe is the inability to accept some products, like human tissue, which is necessary for regenerative purposes due to ethical concerns in some parts of the region. This, along with the high costs and the strict regulations of the government, serves as market restrictions.

Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.

Scope of the Study

Market Segmentation:

By Application
  • General Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Cardiovascular Surgeries
  • Other Applications

By Product
  • Surgical Sealants
  • Soft Tissue Attachments
  • Adhesion Barriers
  • Hemostatic Agents
  • Bone Graft Substitutes
  • Other Products

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled
  • Baxter International, Inc.
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Integra LifeSciences Holdings Corporation
  • CSL Limited

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • CSL Limited
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi S.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Biosurgery Market, by Application
1.4.2 Europe Biosurgery Market, by Product
1.4.3 Europe Biosurgery Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : 2019-Dec - 2016-Apr) Leading Players
Chapter 4. Europe Biosurgery Market by Application
4.1 Europe General Surgeries Market by Country
4.2 Europe Orthopedic Surgeries Market by Country
4.3 Europe Neurological Surgeries Market by Country
4.4 Europe Cardiovascular Surgeries Market by Country
4.5 Europe Other Application Biosurgery Market by Country
Chapter 5. Europe Biosurgery Market by Product
5.1 Europe Surgical sealants Biosurgery Market by Country
5.2 Europe Soft Tissue Attachments Biosurgery Market by Country
5.3 Europe Adhesion Barriers Biosurgery Market by Country
5.4 Europe Hemostatic Agents Biosurgery Market by Country
5.5 Europe Bone Graft Substitutes Biosurgery Market by Country
5.6 Europe Others Biosurgery Market by Country
Chapter 6. Europe Biosurgery Market by Country
6.1 Germany Biosurgery Market
6.1.1 Germany Biosurgery Market by Application
6.1.2 Germany Biosurgery Market by Product
6.2 UK Biosurgery Market
6.2.1 UK Biosurgery Market by Application
6.2.2 UK Biosurgery Market by Product
6.3 France Biosurgery Market
6.3.1 France Biosurgery Market by Application
6.3.2 France Biosurgery Market by Product
6.4 Russia Biosurgery Market
6.4.1 Russia Biosurgery Market by Application
6.4.2 Russia Biosurgery Market by Product
6.5 Spain Biosurgery Market
6.5.1 Spain Biosurgery Market by Application
6.5.2 Spain Biosurgery Market by Product
6.6 Italy Biosurgery Market
6.6.1 Italy Biosurgery Market by Application
6.6.2 Italy Biosurgery Market by Product
6.7 Rest of Europe Biosurgery Market
6.7.1 Rest of Europe Biosurgery Market by Application
6.7.2 Rest of Europe Biosurgery Market by Product
Chapter 7. Company Profiles
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
  • Baxter International, Inc.
  • Johnson and Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Stryker Corporation
  • B. Braun Melsungen AG
  • Sanofi S.A.
  • Becton, Dickinson and Company
  • Integra LifeSciences Holdings Corporation
  • CSL Limited
Note: Product cover images may vary from those shown

Loading
LOADING...